Healthcare Services

Amebiasis Market Global Report 2026 Market Outlook 2026–2030 Exploring New Business Opportunities

March 30, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Market Value Is Anticipated For The Amebiasis Market Over The Period 2026–2030?

The amebiasis market has seen significant expansion in recent years. Its value is expected to increase from $0.88 billion in 2025 to $0.93 billion in 2026, with a compound annual growth rate (CAGR) of 6.6%. The historical growth of this market was propelled by factors including the widespread presence of poor sanitation, restricted availability of clean drinking water, continued reliance on metronidazole-based treatments, the expansion of public health programs, and the accessibility of generic antiparasitic drugs.

The amebiasis market size is projected to experience robust expansion in the coming years. This market is anticipated to reach $1.2 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 6.4%. Factors driving this growth over the forecast period include greater investments in controlling infectious diseases, a heightened demand for advanced diagnostic instruments, wider healthcare access in developing areas, an increasing emphasis on managing antimicrobial resistance, and progress in targeted antiparasitic treatments. Key trends for the projected period encompass a wider availability of combination drug regimens, a greater emphasis on early detection and intervention, an increase in oral antiparasitic drugs, growing public knowledge of waterborne illnesses, and improved access to critical medications.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=21094&type=smp

Which Major Factors Are Driving The Expansion Of The Amebiasis Market?

The increasing prevalence of parasitic infections is projected to propel the expansion of the amebiasis market moving forward. Parasitic infections are conditions originating from protozoa, helminths, or ectoparasites that infiltrate and multiply within human bodies, leading to diverse gastrointestinal, systemic, or tissue-specific ailments. A key contributor to the rise in parasitic infections is insufficient sanitation, as limited availability of clean water and proper waste management facilitates the environmental survival and spread of parasites, thereby escalating the risk of exposure in affected communities. Amebiasis treatment supports efforts to diminish the escalating burden of parasitic infections by enabling prompt diagnosis and effective therapeutic management, which aids in disrupting transmission cycles and preventing progression to severe disease. For example, in February 2025, according to the Centers for Disease Control and Prevention (CDC), a US-based nation’s health protection agency, approximately 100 million amebiasis cases occur globally each year, primarily in developing regions, with roughly 90% remaining asymptomatic, thereby sustaining ongoing community transmission. Consequently, the surge in parasitic infections is driving the growth of the amebiasis market. The growing occurrence of poor sanitation is anticipated to boost the amebiasis market’s expansion going forward. Poor sanitation refers to inadequate access to safely managed toilets, clean water, and fundamental hygiene amenities, which significantly heightens the likelihood of parasitic infections such as Entamoeba histolytica. The widening of sanitation gaps is driven by factors like insufficient infrastructure, rapid urbanization, and restricted access to clean water, all contributing to the persistence and spread of these infections. Amebiasis results in a spectrum of intestinal and extra-intestinal complications, including diarrhea, abdominal pain, and liver abscesses, leading to substantial morbidity and mortality. For instance, in March 2023, according to the United Nations Children’s Fund (UNICEF), a US-based United Nations agency, an estimated 3.6 billion people still lack safe household sanitation, with 1.8 billion lacking access to safe drinking water, and these conditions contribute to roughly 829,000 annual deaths linked to unsafe water, inadequate sanitation, and poor hygiene. Thus, the increasing prevalence of poor sanitation is fueling the growth of the amebiasis market.

How Is The Amebiasis Market Divided Into Its Major Segments?

The amebiasis market covered in this report is segmented –

1) By Type: Metronidazole, Paromomycin, Tinidazole

2) By Route Of Administration: Oral, Intravenous

3) By Application: Hospital, Pharmacy

Subsegments:

1) By Metronidazole: Oral Metronidazole, Intravenous Metronidazole, Combination Therapy with Metronidazole

2) By Paromomycin: Oral Paromomycin, Paromomycin in Combination with Other Drugs

3) By Tinidazole: Oral Tinidazole, Tinidazole for Severe Infections

How Are Trends Transforming The Amebiasis Market Landscape?

Major companies operating within the amebiasis market are increasingly focused on creating advanced remedies, such as ready-to-use oral liquid metronidazole, aimed at boosting patient adherence and the success of treatments. Ready-to-use oral liquid metronidazole is a pre-mixed liquid version of the antibiotic used to combat infections like amebiasis, making it considerably easier for patients who encounter difficulty swallowing pills. Illustratively, in November 2023, Kesin Pharma Corporation, a pharmaceutical firm based in the US, obtained approval from the U.S. Food and Drug Administration for Likmez (metronidazole) oral suspension, 500 mg/5 mL, distinguishing it as the first ready-to-use oral liquid metronidazole formulation. This oral suspension formulation offers a child-friendly alternative, simplifying medication administration for children with precise dosing, thereby ensuring better adherence to treatment plans. The liquid form also offers flexibility in adjusting dosages, enabling healthcare professionals to customize treatment based on unique patient requirements, particularly for differing degrees of infection severity.

Who Are The Prominent Organizations Shaping The Amebiasis Market?

Major companies operating in the amebiasis market are Pfizer Inc., Merck & Co. Inc., Sanofi SA, AbbVie Inc., Bristol-Myers Squibb Company, Novartis AG, F. Hoffmann-La Roche Ltd, Eli Lilly and Company, Takeda Pharmaceutical Company Limited, Boehringer Ingelheim International GmbH, Teva Pharmaceutical Industries Ltd., Cipla Limited, Lupin Limited, Zydus Lifesciences Limited, Hikma Pharmaceuticals PLC, Sun Pharmaceutical Industries Limited, Alkem Laboratories Limited, Aurobindo Pharma Limited, Dr. Reddy’s Laboratories Limited, Mylan NV, Glenmark Pharmaceuticals Limited, Torrent Pharmaceuticals Limited

Read the full amebiasis market report here:

https://www.thebusinessresearchcompany.com/report/amebiasis-global-market-report

Which Region Currently Holds The Largest Share Of The Amebiasis Market?

North America was the largest region in the amebiasis market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the amebiasis market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Amebiasis Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=21094&type=smp

Browse Through More Reports Similar to the Global Amebiasis Market 2026, By The Business Research Company

edible insects global market report

https://www.thebusinessresearchcompany.com/report/edible-insects-global-market-report

anthelmintic drugs global market report

https://www.thebusinessresearchcompany.com/report/anthelmintic-drugs-global-market-report

amla extract global market report

https://www.thebusinessresearchcompany.com/report/amla-extract-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795